Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Latest Price Information on Lucius Ixazomib (2026)

Ixazomib is part of an all-oral treatment regimen. When used in combination with lenalidomide and dexamethasone, it provides a convenient treatment option for patients with multipl···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：281
The U.S. FDA Grants Priority Review Status to Takeda’s Ixazomib for the Treatment of Relapsed/Refrac

On September 9, 2015, Cambridge, Massachusetts, USA, and Osaka, Japan, announced that the U.S. Food and Drug Administration (FDA) had granted priority review status to the New Drug···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：237
The U.S. Food and Drug Administration (FDA) has approved ixazomib for the treatment of multiple myel

The U.S. Food and Drug Administration (FDA) approved ixazomib today for use in combination with two other therapies to treat patients with multiple myeloma who have received at lea···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：244
Important Precautions for Ivosidenib Use

Ivosidenib is available only with a doctor's prescription.Important Precautions for Ivosidenib UseIf you experience any changes in heart rhythm, contact your doctor immediately···【more】
Article source：Captain MedicineRelease date：2026-01-07Recommended：316
Sotorasib(Lumakras)

‌KRAS G12C mutation in non-small cell lung cancer and colorectal cancer‌【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：147
Larotrectinib(Vitrakvi)

Larotrectinib is indicated for the treatment of adult and pediatric patients with solid tumors.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：174
Lorlatinib(Lorbrena)

Non-small cell lung cancer【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：185
Gilteritinib(Xospata)

Gilteritinib is suitable for Leukemia.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：155
Capmatinib(Tabrecta)

Capmatinib is indicated for the treatment of adult patients with metastatic non-small cell lung cancer (NSCLC).【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：272
Selinexor(Xpovio)

Treatment of refractory relapsed multiple myeloma and certain types of diffuse large B-cell lymphoma.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：226
Ivosidenib(Tibsovo)

It is indicated for patients with susceptible isocitrate dehydrogenase-1 (IDH1) mutations confirmed by a test method approved by the FDA.【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：199
Exkivity(Mobocertinib)

Exkivity is suitable for specific non-small cell lung cancer(NSCLC).【more】
Article source：Captain MedicineRelease date：2026-01-06Recommended：192

home page previous 41 41/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More